Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
SAB Biotherapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Biological Products, (No Diagnostic Substances)
No intraday reading yet this session.
SAB Biotherapeutics, Inc. has 6 disclosed suppliers and 1 disclosed customer. Each one is named in an SEC filing, either SAB Biotherapeutics, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“The Emergent Agreements contemplate that we will enter into one or more binding Master Manufacturing Services Agreements, whereby Emergent will provide contract development and manufacturing services to produce our fully-human polyclonal antibody products.”
FILING10-K0001833214-26-000003cik 0001833214
“For SAB-142, Avance Clinical PTY, Ltd ("Avance"), acts as the contract research organization ("CRO") overseeing our Phase 1 safety study.”
FILING10-K0001833214-26-000003cik 0001833214
“Fortrea will act as the CRO overseeing our Phase 2b efficacy and safety study for SAB-142.”
FILING10-K0001833214-26-000003cik 0001833214
“We acquired all the intellectual property rights to Tc Bovine and the production platform from Sanford Applied Biosciences, a wholly owned subsidiary of Sanford Health, to develop targeted hIgG to specific targets and advance clinical development and commercialization.”
FILING10-K0001833214-26-000003cik 0001833214
“In accordance with the terms of the Cantor Sales Agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $20,000,000 from time to time through Cantor, acting as our sales agent.”
FILING10-K0001833214-26-000003cik 0001833214
“In accordance with the terms of the UBS Sales Agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $75,000,000 from time to time through UBS, acting as our sales agent.”
FILING10-K0001833214-26-000003cik 0001833214
“We had various grants from the US Department of Defense that terminated in 2022.”
FILING10-K0001833214-26-000003cik 0001833214
Watchlist prices, news filtered to it, and its next report on your desk.
SABS (SAB Biotherapeutics, Inc.) has 6 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.